Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

- PMLiVE

Inizio Ignite sparks a new era of connected advisory solutions

The new advisory partner brings together Research Partnership, Putnam, Vynamic and STEM

- PMLiVE

PMGroup Worldwide welcomes MAD World Summit

The MAD World Summit is dedicated to transforming workplace culture and employee mental health and well-being

- PMLiVE

Moderna and Merck announce data from melanoma combination therapy study

Skin cancer is one of the most common cancers in the US, with melanoma accounting for the majority of skin cancer deaths

- PMLiVE

Prescient Healthcare Group acquires Uptake

Prescient acquires Uptake, with a focus on exceptional client delivery and impact in the pharmaceutical and biotech industry

- PMLiVE

Skin Health Alliance donates funds to British Skin Foundation to drive research

Part of the funding will be used for research into skin diseases in kidney transplant patients

- PMLiVE

smartbax licenses compound from Aicuris for next-generation antibiotic development

The new programme addresses the urgent unmet medical need for new therapies to tackle antibiotic-resistant infections

- PMLiVE

First impressions matter: Why getting your onboarding right is key for digital engagement

As pharma organisations invest extensively in creating engaging content, the onboarding process must not be overlooked. Seamless onboarding is the key to ensuring that HCPs not only meet regulatory standards,...

Graphite Digital

- PMLiVE

Novartis’ ianalumab receives FDA Breakthrough Therapy designation for Sjögren’s disease

Approximately half of those with Sjögren’s disease are thought to be undiagnosed

- PMLiVE

DEBRA Research and University Medical Center Groningen launch clinical trial site for epidermolysis bullosa

This rare genetic disorder causes skin to become extremely fragile

Amiculum meets Trishna Bharadia, patient engagement and health advocate

How can pharma build genuine partnerships with patient communities?

Patient engagement is not optional in pharma – it’s integral. Meaningful partnerships with patients, caregivers and advocates must shape every stage of healthcare and medicines development, driving better outcomes, equity...

Amiculum

- PMLiVE

Vibrant Therapeutics raises $61m in funding to advance intelligent therapeutics pipeline

The financing includes new investors Pfizer Ventures and Apricot Capital, bringing the total capital raised to $100m

- PMLiVE

Vibrant Therapeutics appoints Han Lee as co-CEO

Lee previously held senior roles at ImmPACT Bio, Neogene Therapeutics and AstraZeneca

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links